{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:57:59Z","timestamp":1793127479282,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107326","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T02:07:40Z","timestamp":1722046060000},"page":"107326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["AAV-aMTD-Parkin, a therapeutic gene delivery cargo, enhances motor and cognitive functions in Parkinson's and Alzheimer\u2019s diseases"],"prefix":"10.1016","volume":"208","author":[{"given":"Seokwon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangsun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonjin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjae","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daye","family":"Ann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jisoo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ki","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daewoong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2024.107326_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040559","article-title":"Parkin as a molecular bridge linking Alzheimer's and Parkinson's diseases?","volume":"12","author":"Checler","year":"2022","journal-title":"Biomolecules"},{"issue":"2 Suppl 1","key":"10.1016\/j.phrs.2024.107326_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(00)80077-3","article-title":"What is oxidative stress?","volume":"49","author":"Betteridge","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2024.107326_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.phrs.2024.107326_bib4","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9","key":"10.1016\/j.phrs.2024.107326_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2174\/1389557519666191104110908","article-title":"Parkinson's Disease: A Review from Pathophysiology to Treatment","volume":"20","author":"Marino","year":"2020","journal-title":"Mini Rev. Med Chem."},{"issue":"10291","key":"10.1016\/j.phrs.2024.107326_bib6","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.phrs.2024.107326_bib7","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1111\/febs.14607","article-title":"Determinants of dopaminergic neuron loss in Parkinson's disease","volume":"285","author":"Surmeier","year":"2018","journal-title":"FEBS J."},{"issue":"18","key":"10.1016\/j.phrs.2024.107326_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1193","article-title":"Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological alpha-synuclein","volume":"6","author":"Chung","year":"2020","journal-title":"Sci. Adv."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2024.107326_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem"},{"issue":"12","key":"10.1016\/j.phrs.2024.107326_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122623","article-title":"Neuron-Astrocyte Interactions in Parkinson's Disease","volume":"9","author":"Miyazaki","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.phrs.2024.107326_bib11","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1073\/pnas.94.8.4113","article-title":"Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments","volume":"94","author":"Spillantini","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2024.107326_bib12","first-page":"1720621","article-title":"Alpha-Synuclein in Parkinson's disease: from pathogenetic dysfunction to potential clinical application","volume":"2016","author":"Xu","year":"2016","journal-title":"Park. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2024.107326_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib14","article-title":"Mitochondrial dysfunction in parkinson's disease-cause or consequence?","volume":"8","author":"Chen","year":"2019","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.phrs.2024.107326_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des. Devel Ther."},{"issue":"4","key":"10.1016\/j.phrs.2024.107326_bib16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: Measurement using accurate biomarkers","volume":"48","author":"Seet","year":"2010","journal-title":"Free Radic. Biol. Med"},{"issue":"27","key":"10.1016\/j.phrs.2024.107326_bib17","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1523\/JNEUROSCI.0212-07.2007","article-title":"Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone","volume":"27","author":"Yadava","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107326_bib18","article-title":"Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities","volume":"8","author":"Prasuhn","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","article-title":", alpha-synuclein in the pathophysiology of Alzheimer's disease","volume":"14","author":"Twohig","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"14","key":"10.1016\/j.phrs.2024.107326_bib20","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib21","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41467-018-04422-2","article-title":", alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease","volume":"9","author":"Ludtmann","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2024.107326_bib22","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","journal-title":"Hum. Mol. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107326_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104756","article-title":"Mitophagy in Parkinson's disease: From pathogenesis to treatment target","volume":"138","author":"Dernie","year":"2020","journal-title":"Neurochem Int"},{"issue":"7","key":"10.1016\/j.phrs.2024.107326_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson's disease: from pathogenesis to treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phrs.2024.107326_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson's disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-017-0174-z","article-title":"The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activity","volume":"12","author":"Ando","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib29","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"18","key":"10.1016\/j.phrs.2024.107326_bib31","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Perez Ortiz","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","article-title":"Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer's disease models and human brains","volume":"141","author":"Vaillant-Beuchot","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107326_bib34","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1080\/15548627.2021.1963630","article-title":"Endolysosome and autophagy dysfunction in Alzheimer disease","volume":"17","author":"Hung","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2024.107326_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113321","article-title":"Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis","volume":"330","author":"Weidling","year":"2020","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9010063","article-title":"Mitochondrial dysfunction in Alzheimer's disease: a biomarker of the future?","volume":"9","author":"Bell","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tins.2020.10.004","article-title":"Mitochondria and Calcium in Alzheimer's Disease: From Cell Signaling to Neuronal Cell Death","volume":"44","author":"Calvo-Rodriguez","year":"2021","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2024.107326_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.nbd.2009.08.009","article-title":"Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions","volume":"36","author":"Witte","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","article-title":"Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease","volume":"79","author":"Salloway","year":"2022","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2024.107326_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.674071","article-title":"Insights Into Parkin-Mediated Mitophagy in Alzheimer's disease: a systematic review","volume":"13","author":"Goudarzi","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2024.107326_bib43","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","article-title":"Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains","volume":"24","author":"Ye","year":"2015","journal-title":"Hum. Mol. Genet"},{"issue":"4","key":"10.1016\/j.phrs.2024.107326_bib44","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/hmg\/ddv616","article-title":"PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease","volume":"25","author":"Martin-Maestro","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"5","key":"10.1016\/j.phrs.2024.107326_bib45","first-page":"437","article-title":"Onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"26","author":"Naveed","year":"2021","journal-title":"J. Pedia Pharm. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2024.107326_bib46","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/mds.23546","article-title":"New animal models of Parkinson's disease","volume":"26","author":"Dehay","year":"2011","journal-title":"Mov. Disord."},{"issue":"1-3","key":"10.1016\/j.phrs.2024.107326_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-2999(94)90082-5","article-title":"Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task","volume":"255","author":"Nabeshima","year":"1994","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib48","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0306-4522(96)00161-3","article-title":"Role of nitric oxide and cyclic GMP in the dizocilpine-induced impairment of spontaneous alternation behavior in mice","volume":"74","author":"Yamada","year":"1996","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1566523220999200917114101","article-title":"Exploring the Role of Gene Therapy for Neurological Disorders","volume":"21","author":"Puranik","year":"2021","journal-title":"Curr. Gene Ther."},{"issue":"5","key":"10.1016\/j.phrs.2024.107326_bib50","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.phrs.2024.107326_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12121979","article-title":"Emerging perspectives on gene therapy delivery for neurodegenerative and neuromuscular disorders","volume":"12","author":"Gomez Limia","year":"2022","journal-title":"J. Pers. Med"},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymthe.2005.03.022","article-title":"Regulatable gene expression systems for gene therapy applications: progress and future challenges","volume":"12","author":"Goverdhana","year":"2005","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2024.107326_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"7-8","key":"10.1016\/j.phrs.2024.107326_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/hum.2019.367","article-title":"Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery","volume":"31","author":"Castle","year":"2020","journal-title":"Hum. Gene Ther."},{"issue":"12","key":"10.1016\/j.phrs.2024.107326_bib55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"alpha-Synuclein and dopamine at the crossroads of Parkinson's disease","volume":"33","author":"Venda","year":"2010","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107326_bib56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mds.27607","article-title":"The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration","volume":"34","author":"Mor","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.phrs.2024.107326_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jnr.22178","article-title":"Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function","volume":"88","author":"Rosen","year":"2010","journal-title":"J. Neurosci. Res"},{"issue":"11","key":"10.1016\/j.phrs.2024.107326_bib58","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/hmg\/ddr091","article-title":"Parkin mediates beclin-dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models","volume":"20","author":"Khandelwal","year":"2011","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.phrs.2024.107326_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117322","article-title":"Parkin overexpression attenuates Abeta-induced mitochondrial dysfunction in HEK293 cells by restoring impaired mitophagy","volume":"244","author":"Wang","year":"2020","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107326_bib60","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/hmg\/ddt501","article-title":"Parkin overexpression ameliorates hippocampal long-term potentiation and beta-amyloid load in an Alzheimer's disease mouse model","volume":"23","author":"Hong","year":"2014","journal-title":"Hum. Mol. Genet"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824002718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T23:10:23Z","timestamp":1726787423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824002718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"alternative-id":["S1043661824002718"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107326","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-aMTD-Parkin, a therapeutic gene delivery cargo, enhances motor and cognitive functions in Parkinson's and Alzheimer\u2019s diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107326"}}